Completing the circle, TSLP has in turn been shown to activate STAT5 in malignant CTCL cells thereby promoting both their proliferation and production of IL-4 and IL-13 (Takahashi et al., 2016). This evidence concerns the gene TSLP and primary cutaneous T-cell non-Hodgkin lymphoma.